Phosphatase and Pseudo-Phosphatase Functions of Phosphatase of Regenerating Liver 3 (PRL-3) Are Insensitive to Divalent Metals In Vitro.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
received:
09
06
2023
accepted:
26
07
2023
medline:
28
8
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
epublish
Résumé
Phosphatase of regenerating liver 3 (PRL-3) is associated with cancer metastasis and has been shown to interact with the cyclin and CBS domain divalent metal cation transport mediator (CNNM) family of proteins to regulate the intracellular concentration of magnesium and other divalent metals. Despite PRL-3's importance in cancer, factors that regulate PRL-3's phosphatase activity and its interactions with CNNM proteins remain unknown. Here, we show that divalent metal ions, including magnesium, calcium, and manganese, have no impact on PRL-3's structure, stability, phosphatase activity, or CNNM binding capacity, indicating that PRL-3 does not act as a metal sensor, despite its interaction with CNNM metal transporters. In vitro approaches found that PRL-3 is a broad but not indiscriminate phosphatase, with activity toward di- and tri-nucleotides, phosphoinositols, and NADPH but not other common metabolites. Although calcium, magnesium, manganese, and zinc-binding sites were predicted near the PRL-3 active site, these divalent metals did not specifically alter PRL-3's phosphatase activity toward a generic substrate, its transition from an inactive phospho-cysteine intermediate state, or its direct binding with the CBS domain of CNNM. PRL-3's insensitivity to metal cations negates the possibility of its role as an intracellular metal content sensor for regulating CNNM activity. Further investigation is warranted to define the regulatory mechanisms governing PRL-3's phosphatase activity and CNNM interactions, as these findings could hold potential therapeutic implications in cancer treatment.
Identifiants
pubmed: 37636930
doi: 10.1021/acsomega.3c04095
pmc: PMC10448674
doi:
Types de publication
Journal Article
Langues
eng
Pagination
30578-30589Informations de copyright
© 2023 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
J Biol Chem. 2012 Mar 16;287(12):9322-6
pubmed: 22275360
J Clin Invest. 2014 Dec;124(12):5398-410
pubmed: 25347473
Sci Rep. 2020 Jul 30;10(1):12879
pubmed: 32733084
FEBS Lett. 2004 May 7;565(1-3):181-7
pubmed: 15135076
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):2925-2934
pubmed: 30718434
J Biol Inorg Chem. 2006 Nov;11(8):1049-62
pubmed: 16924557
Neurosci Bull. 2015 Jun;31(3):331-7
pubmed: 25854679
Biochemistry. 2011 Sep 6;50(35):7579-90
pubmed: 21806020
Pathol Oncol Res. 2009 Dec;15(4):555-60
pubmed: 19247814
Biomolecules. 2014 Apr 17;4(2):419-34
pubmed: 24970223
J Biol Chem. 2020 Aug 14;295(33):11682-11692
pubmed: 32571875
J Transl Med. 2016 Mar 15;14:71
pubmed: 26975394
J Biol Chem. 2018 Dec 28;293(52):19998-20007
pubmed: 30341174
Anal Biochem. 2005 Mar 1;338(1):32-8
pubmed: 15707933
Structure. 2020 Mar 3;28(3):324-335.e4
pubmed: 31864811
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4706-4715
pubmed: 30770447
J Biol Chem. 2004 Mar 19;279(12):11882-9
pubmed: 14704153
Am J Physiol. 1992 Apr;262(4 Pt 1):C1024-30
pubmed: 1566808
Mol Microbiol. 2014 Oct;94(2):367-82
pubmed: 25155747
Cell Calcium. 2019 Nov;83:102078
pubmed: 31493712
Nat Methods. 2009 Oct;6(10):737-40
pubmed: 19718032
Int J Mol Sci. 2019 Mar 06;20(5):
pubmed: 30845649
Nucleic Acids Res. 2022 Jul 5;50(W1):W90-W98
pubmed: 35544232
J Biol Chem. 2016 May 13;291(20):10716-25
pubmed: 26969161
J Chem Educ. 1967 Feb;44(2):84-8
pubmed: 6040828
Curr Opin Clin Nutr Metab Care. 2022 Jan 1;25(1):50-55
pubmed: 34725313
Science. 2001 Nov 9;294(5545):1343-6
pubmed: 11598267
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2221083120
pubmed: 36972446
Ann Surg Oncol. 2013 Jan;20(1):305-17
pubmed: 23064776
EMBO Rep. 2016 Dec;17(12):1890-1900
pubmed: 27856537
Histochem Cell Biol. 2016 Jul;146(1):99-111
pubmed: 27015884
Methods Enzymol. 2014;541:161-7
pubmed: 24674070
J Gen Physiol. 2003 Jan;121(1):49-60
pubmed: 12508053
FASEB J. 2021 Mar;35(3):e21344
pubmed: 33566385
Surg Today. 2007;37(8):646-51
pubmed: 17643206
Sci Rep. 2016 Nov 03;6:36346
pubmed: 27808280
Sci Rep. 2021 May 13;11(1):10302
pubmed: 33986418
J Biochem. 2019 Mar 1;165(3):219-225
pubmed: 30476181
J Cell Sci. 2016 Nov 1;129(21):4130-4142
pubmed: 27656108
Ann Oncol. 2006 Oct;17(10):1517-22
pubmed: 16873432
Pathobiology. 2014;81(1):1-7
pubmed: 23989302
PLoS Biol. 2021 Dec 20;19(12):e3001496
pubmed: 34928937
J Biol Chem. 2021 Dec;297(6):101374
pubmed: 34732319
Toxicology. 1981;22(1):9-21
pubmed: 6175051
Mol Cell Biol. 1994 Jun;14(6):3752-62
pubmed: 8196618
Anal Biochem. 1999 Aug 15;273(1):73-80
pubmed: 10452801
Sci Rep. 2017 Dec;7(1):48
pubmed: 28246390
Biochem Biophys Res Commun. 1998 Mar 17;244(2):421-7
pubmed: 9514946
J Mol Biol. 2019 Aug 9;431(17):3056-3067
pubmed: 31207239
Coord Chem Rev. 2016 Nov 15;327-328:70-83
pubmed: 27890939
J Biol Chem. 2017 Jan 20;292(3):786-801
pubmed: 27899452
Oncogene. 2015 Feb 19;34(8):986-95
pubmed: 24632616
Nature. 2009 Aug 13;460(7257):823-30
pubmed: 19675642
Bioinformatics. 2022 Sep 15;38(18):4428-4429
pubmed: 35904542